GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prim SA (XMAD:PRM) » Definitions » YoY EBITDA Growth

Prim (XMAD:PRM) YoY EBITDA Growth : 194.20% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Prim YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Prim's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 194.20%.

Prim's EBITDA per Share for the six months ended in Dec. 2023 was €0.41.

Prim YoY EBITDA Growth Historical Data

The historical data trend for Prim's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prim YoY EBITDA Growth Chart

Prim Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.72 -30.87 97.07 -34.50 43.23

Prim Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.14 -49.31 -81.07 25.05 194.20

Prim YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Prim's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(1.64-1.145)/ | 1.145 |
=43.23 %

Prim's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(0.406-0.138)/ | 0.138 |
=194.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prim YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Prim's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Prim (XMAD:PRM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prim SA (XMAD:PRM) » Definitions » YoY EBITDA Growth
Comparable Companies
OCSE:VJBA OCSE:KRE OCSE:LASP OCSE:MNBA OCSE:NRDF OCSE:HVID OCSE:DJUR OCSE:GRLA OCSE:LOLB OCSE:SPKSJF ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD OCSE:COLO B TSE:4543 WST XSWX:STMN
Traded in Other Exchanges
5P1:Germany
Address
Calle F, número 15, Polígono Industrial 1, Móstoles, Madrid, ESP, 28938
Website
http://www.prim.es
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.